ReviewTherapeutic advances in urology2014

Potential utility of cancer-specific biomarkers for assessing response to hormonal treatments in metastatic prostate cancer.

Jack Schalken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.